Dasatinib induces complete remission in a patient with primary cerebral involvement of B-cell chronic lymphocytic leukemia failing chemotherapy

Blood. 2010 Oct 7;116(14):2617-8. doi: 10.1182/blood-2010-04-279786.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Brain / drug effects
  • Brain / pathology
  • Dasatinib
  • Humans
  • Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy*
  • Leukemia, Lymphocytic, Chronic, B-Cell / pathology*
  • Magnetic Resonance Imaging
  • Male
  • Protein Kinase Inhibitors / therapeutic use*
  • Pyrimidines / therapeutic use*
  • Remission Induction
  • Thiazoles / therapeutic use*

Substances

  • Protein Kinase Inhibitors
  • Pyrimidines
  • Thiazoles
  • Dasatinib